Cofrex provides a unique business model that allows pharmaceutical companies to access and thrive in a complex region in Africa, established in 2012, specialized in regulatory affairs which has effectively registered and launched 384 products in 17 countries, achieving a 10M€ annual turnover , while Cofrex DWC LLC is specialized in marketing in Dubai.
Cofrex works on an exclusive basis, through local agents in each territory and the distribution is conducted through a reliable European supply chain network.